ADO
Click for more information
5.00% 2.1¢ anteotech ltd

DCN - Clinical Study, page-14

  1. ds
    7,131 Posts.
    clock Created with Sketch.
    29/03/16
    23:34
    Post #: 17377749
    Does that mean you would share my view that having DiaSource and it's production and distribution channels would be a plus that we can 'jump the queue' so to speak by launching M&G fuelled diagnostics via DiaSource rather than have to convince any big pharma to integrate?
    ADO Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 19  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.001(5.00%) 		Mkt cap ! $51.84M
Open High Low Value Volume
2.0¢ 2.1¢ 1.9¢ $24.34K 1.215M

Buyers (Bids)

No. Vol. Price($)
1 6000 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1080621 4
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.